Three-year efficacy and side effect of adefovir dipivoxil for the treatment of the old patients with chronic hepatitis B virus infection / 中华实验和临床病毒学杂志
Chinese Journal of Experimental and Clinical Virology
;
(6): 379-381, 2012.
Artículo
en Chino
| WPRIM
| ID: wpr-305031
ABSTRACT
<p><b>OBJECTIVE</b>To investigate 3-year antiviral efficacy and side effect of adefovir dipivoxil (ADV) on the old patients with hepatitis B chronic infection.</p><p><b>METHODS</b>31 HBeAg-negative chronic hepatitis B virus infected old patients (include 8 patients with chronic hepatitis B and 23 patients with liver cirrhosis) with serum HBV DNA levels > 1000 copies/ml, and ALT > 2 times the upper limit of normal, without company with other liver diseases, cancer, renal dysfunction, and autoimmune disease. All the patients were treated with ADV orally (10 mg once daily) for 36 months. HBV DNA and biochemical and blood routine indexes were checked after treated.</p><p><b>RESULT</b>Serum total bilirubin, direct bilirubin, alamine aminotransferase, aspartate aminotransferase and load of HBV DNA decrease significantly after therapy (P < 0. 001). Other biochemical indexs and blood routine are no significant changes (P > 0.05).</p><p><b>CONCLUSION</b>The way to treat with ADV is safe and effective for old patients with chronic hepatitis B virus infection.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Antivirales
/
Factores de Tiempo
/
Virología
/
Adenina
/
Hepatitis B Crónica
/
Usos Terapéuticos
/
Quimioterapia
/
Organofosfonatos
Límite:
Anciano
/
Aged80
/
Femenino
/
Humanos
/
Masculino
Idioma:
Chino
Revista:
Chinese Journal of Experimental and Clinical Virology
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS